Literature DB >> 14978688

Cerebrospinal fluid Abeta42 levels in multiple system atrophy.

Marcel M Verbeek, W Farid Abdo, Danielle De Jong, Martin W I M Horstink, Berry P H Kremer, Bastiaan R Bloem.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14978688     DOI： 10.1002/mds.10687

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  6 in total

1.  Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression.

Authors:  Min Shi; Joshua Bradner; Aneeka M Hancock; Kathryn A Chung; Joseph F Quinn; Elaine R Peskind; Douglas Galasko; Joseph Jankovic; Cyrus P Zabetian; Hojoong M Kim; James B Leverenz; Thomas J Montine; Carmen Ginghina; Un Jung Kang; Kevin C Cain; Yu Wang; Jan Aasly; David Goldstein; Jing Zhang
Journal:  Ann Neurol       Date:  2011-03-11       Impact factor: 10.422

Review 2.  Biological fluid biomarkers in neurodegenerative parkinsonism.

Authors:  Michael Eller; David R Williams
Journal:  Nat Rev Neurol       Date:  2009-09-01       Impact factor: 42.937

3.  Tauopathies and synucleinopathies: do cerebrospinal fluid beta-amyloid peptides reflect disease-specific pathogenesis?

Authors:  B Mollenhauer; M Bibl; H Esselmann; P Steinacker; C Trenkwalder; J Wiltfang; M Otto
Journal:  J Neural Transm (Vienna)       Date:  2007-02-22       Impact factor: 3.850

Review 4.  Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: a pathogenetically based approach.

Authors:  Karin D van Dijk; Charlotte E Teunissen; Benjamin Drukarch; Connie R Jimenez; Henk J Groenewegen; Henk W Berendse; Wilma D J van de Berg
Journal:  Neurobiol Dis       Date:  2010-05-06       Impact factor: 5.996

Review 5.  Cerebrospinal Fluid Biomarkers in Multiple System Atrophy Relative to Parkinson's Disease: A Meta-Analysis.

Authors:  Dan Xie; Ling Feng; Hongyan Huang; Quanzhen Zhao; Pingping Ning; Qiuyan Shen; Haitao Lu; Fang Xu; Yanming Xu
Journal:  Behav Neurol       Date:  2021-05-31       Impact factor: 3.342

6.  Parkinson's Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonism.

Authors:  Anouke van Rumund; Marjolein B Aerts; Rianne A J Esselink; Frederick J A Meijer; Marcel M Verbeek; Bastiaan R Bloem
Journal:  BMC Neurol       Date:  2018-05-16       Impact factor: 2.474
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.